NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 4,970 shares of NeueHealth stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the transaction, the chief financial officer now directly owns 17,747 shares in the company, valued at approximately $130,085.51. This trade represents a 21.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
NeueHealth Trading Down 1.2 %
Shares of NeueHealth stock opened at $7.33 on Friday. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59. The company has a market cap of $60.73 million, a P/E ratio of -0.14 and a beta of 0.57. The stock has a 50-day moving average price of $5.60 and a 200 day moving average price of $5.42.
Institutional Trading of NeueHealth
A number of hedge funds have recently made changes to their positions in NEUE. Renaissance Technologies LLC purchased a new stake in NeueHealth in the 2nd quarter worth approximately $312,000. NEA Management Company LLC acquired a new position in shares of NeueHealth in the second quarter worth $14,834,000. Deer Management Co. LLC purchased a new stake in shares of NeueHealth during the second quarter worth $5,436,000. Finally, Partners Group Holding AG purchased a new position in NeueHealth in the third quarter valued at about $463,000. 63.88% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
View Our Latest Stock Analysis on NeueHealth
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
- Five stocks we like better than NeueHealth
- The 3 Best Blue-Chip Stocks to Buy Now
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What Are Earnings Reports?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 3 Stocks to Consider Buying in October
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.